EUVIMEDEUVIMED entdecken
Crossref

HRAS ‐related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects

Aude Beyens, Charlotte Lietaer, Kathleen Claes, Elfride De Baere, Marleen Goeteyn, Bob Lerut, Hannes Syryn iD, Olivier Vanakker, Joni Van der Meulen, Lieve Vanwalleghem, Bert Callewaert

Clinical Genetics · 2023

DOI: 10.1111/cge.14323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2023. Verfasst von Aude Beyens und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium. Hauptthemen laut MEDLINE: Nevus, Skin Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: European Academy of Dermatology and Venereology, Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermal nevus syndrome (ENS) comprises a heterogeneous group of neurocutaneous syndromes associated with the presence of epidermal nevi and variable extracutaneous manifestations. Postzygotic activating HRAS pathogenic variants were previously identified in nevus sebaceous (NS), keratinocytic epidermal nevus (KEN), and different ENS, including Schimmelpenning–Feuerstein–Mims and cutaneous‐skeletal‐hypophosphatasia syndrome (CSHS). Skeletal involvement in HRAS ‐related ENS ranges from localized bone dysplasia in association with KEN to fractures and limb deformities in CSHS. We describe the first association of HRAS ‐related ENS and auricular atresia, thereby expanding the disease spectrum with first branchial arch defects if affected by the mosaic variant. In addition, this report illustrates the first concurrent presence of verrucous EN, NS, and nevus comedonicus (NC), indicating the possibility of mosaic HRAS variation as an underlying cause of NC. Overall, this report extends the pleiotropy of conditions associated with mosaic pathogenic variants in HRAS affecting ectodermal and mesodermal progenitor cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NevusSkin NeoplasmsHumansSyndromeBranchial RegionProto-Oncogene Proteins p21(ras)

Stichwörter der Autor:innen

HRASauricular atresiabranchial archepidermal nevus syndromemicrotianevus comedonicusnevus sebaceoussomatic mosaicism

Substanzen

HRAS protein, humanProto-Oncogene Proteins p21(ras)

Autor:innen und Institutionen

  • Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium.
  • Department of Biomolecular Medicine, Ghent University Hospital, Ghent, Belgium.
  • Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Department of Otorhinolaryngology, AZ Sint Jan Brugge-Oostende, Bruges, Belgium.
  • Department of Dermatology, AZ Sint Jan Brugge-Oostende, Bruges, Belgium.
  • Molecular Diagnostics Ghent University Hospital (MDG), Ghent University Hospital, Ghent, Belgium.

ORCID-Profile: Hannes Syryn

Förderung

  • European Academy of Dermatology and Venereology
  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Beyens, A., Lietaer, C., Claes, K., De Baere, E., Goeteyn, M., Lerut, B., Syryn, H., Vanakker, O., Van der Meulen, J., Vanwalleghem, L., & Callewaert, B. (2023). HRAS ‐related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects. Clinical Genetics. https://doi.org/10.1111/cge.14323

Vancouver

Beyens A, Lietaer C, Claes K, De Baere E, Goeteyn M, Lerut B, et al. HRAS ‐related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects. Clinical Genetics. 2023. doi:10.1111/cge.14323

BibTeX
@article{Beyens2023,
  author = {Beyens, Aude and Lietaer, Charlotte and Claes, Kathleen and De Baere, Elfride and Goeteyn, Marleen and Lerut, Bob and Syryn, Hannes and Vanakker, Olivier and Van der Meulen, Joni and Vanwalleghem, Lieve and Callewaert, Bert},
  title = {HRAS ‐related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects},
  journal = {Clinical Genetics},
  year = {2023},
  doi = {10.1111/cge.14323}
}
Kostenlos starten →